ID PILRB_HUMAN Reviewed; 227 AA. AC Q9UKJ0; Q69YF9; Q9HBS0; DT 07-MAR-2006, integrated into UniProtKB/Swiss-Prot. DT 01-MAY-2000, sequence version 1. DT 27-MAR-2024, entry version 161. DE RecName: Full=Paired immunoglobulin-like type 2 receptor beta; DE AltName: Full=Activating receptor PILR-beta; DE AltName: Full=Cell surface receptor FDFACT; DE Flags: Precursor; GN Name=PILRB; Synonyms=FDFACT; ORFNames=PP1551; OS Homo sapiens (Human). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; OC Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae; OC Homo. OX NCBI_TaxID=9606; RN [1] RP NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1). RX PubMed=10660620; DOI=10.1074/jbc.275.6.4467; RA Mousseau D.D., Banville D., L'Abbe D., Bouchard P., Shen S.H.; RT "PILRalpha, a novel immunoreceptor tyrosine-based inhibitory motif-bearing RT protein, recruits SHP-1 upon tyrosine phosphorylation and is paired with RT the truncated counterpart PILRbeta."; RL J. Biol. Chem. 275:4467-4474(2000). RN [2] RP NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1). RA Bates E.E.; RL Submitted (APR-2000) to the EMBL/GenBank/DDBJ databases. RN [3] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3). RX PubMed=15498874; DOI=10.1073/pnas.0404089101; RA Wan D., Gong Y., Qin W., Zhang P., Li J., Wei L., Zhou X., Li H., Qiu X., RA Zhong F., He L., Yu J., Yao G., Jiang H., Qian L., Yu Y., Shu H., Chen X., RA Xu H., Guo M., Pan Z., Chen Y., Ge C., Yang S., Gu J.; RT "Large-scale cDNA transfection screening for genes related to cancer RT development and progression."; RL Proc. Natl. Acad. Sci. U.S.A. 101:15724-15729(2004). RN [4] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2). RC TISSUE=Testis; RX PubMed=17974005; DOI=10.1186/1471-2164-8-399; RA Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U., RA Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H., Heubner D., RA Hoerlein A., Michel G., Wedler H., Koehrer K., Ottenwaelder B., Poustka A., RA Wiemann S., Schupp I.; RT "The full-ORF clone resource of the German cDNA consortium."; RL BMC Genomics 8:399-399(2007). RN [5] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1). RC TISSUE=Peripheral blood leukocyte; RX PubMed=15489334; DOI=10.1101/gr.2596504; RG The MGC Project Team; RT "The status, quality, and expansion of the NIH full-length cDNA project: RT the Mammalian Gene Collection (MGC)."; RL Genome Res. 14:2121-2127(2004). CC -!- FUNCTION: Paired receptors consist of highly related activating and CC inhibitory receptors and are widely involved in the regulation of the CC immune system. PILRB is thought to act as a cellular signaling CC activating receptor that associates with ITAM-bearing adapter molecules CC on the cell surface. CC -!- SUBCELLULAR LOCATION: Membrane {ECO:0000305}; Single-pass type I CC membrane protein {ECO:0000305}. CC -!- ALTERNATIVE PRODUCTS: CC Event=Alternative splicing; Named isoforms=3; CC Name=1; CC IsoId=Q9UKJ0-1; Sequence=Displayed; CC Name=2; CC IsoId=Q9UKJ0-2; Sequence=VSP_017504; CC Name=3; CC IsoId=Q9UKJ0-3; Sequence=VSP_017503, VSP_017504; CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; AF161081; AAD52965.1; -; mRNA. DR EMBL; AJ400845; CAC19193.1; -; mRNA. DR EMBL; AJ400846; CAC19194.1; -; mRNA. DR EMBL; AF217981; AAG17224.1; -; mRNA. DR EMBL; AL834317; CAH10714.1; -; mRNA. DR EMBL; AL834336; CAH10711.1; -; mRNA. DR EMBL; BC050547; AAH50547.1; -; mRNA. DR CCDS; CCDS43622.1; -. [Q9UKJ0-1] DR RefSeq; NP_839956.1; NM_178238.3. [Q9UKJ0-1] DR PDB; 4NFC; X-ray; 2.20 A; A/B=32-150. DR PDB; 4NFD; X-ray; 1.71 A; A=32-150. DR PDBsum; 4NFC; -. DR PDBsum; 4NFD; -. DR AlphaFoldDB; Q9UKJ0; -. DR SMR; Q9UKJ0; -. DR BioGRID; 119015; 45. DR IntAct; Q9UKJ0; 4. DR STRING; 9606.ENSP00000391748; -. DR UniLectin; Q9UKJ0; -. DR GlyCosmos; Q9UKJ0; 1 site, No reported glycans. DR GlyGen; Q9UKJ0; 1 site. DR iPTMnet; Q9UKJ0; -. DR PhosphoSitePlus; Q9UKJ0; -. DR BioMuta; PILRB; -. DR DMDM; 74761987; -. DR MassIVE; Q9UKJ0; -. DR PaxDb; 9606-ENSP00000391748; -. DR PeptideAtlas; Q9UKJ0; -. DR Antibodypedia; 30676; 161 antibodies from 29 providers. DR DNASU; 29990; -. DR Ensembl; ENST00000448382.5; ENSP00000415775.1; ENSG00000121716.21. [Q9UKJ0-3] DR Ensembl; ENST00000452089.5; ENSP00000391748.1; ENSG00000121716.21. [Q9UKJ0-1] DR Ensembl; ENST00000609309.3; ENSP00000477365.1; ENSG00000121716.21. [Q9UKJ0-1] DR GeneID; 29990; -. DR KEGG; hsa:29990; -. DR MANE-Select; ENST00000609309.3; ENSP00000477365.1; NM_178238.4; NP_839956.1. DR UCSC; uc003uun.4; human. [Q9UKJ0-1] DR AGR; HGNC:18297; -. DR CTD; 29990; -. DR DisGeNET; 29990; -. DR GeneCards; PILRB; -. DR HGNC; HGNC:18297; PILRB. DR HPA; ENSG00000121716; Low tissue specificity. DR MIM; 605342; gene. DR neXtProt; NX_Q9UKJ0; -. DR OpenTargets; ENSG00000121716; -. DR PharmGKB; PA134906700; -. DR VEuPathDB; HostDB:ENSG00000121716; -. DR eggNOG; ENOG502SUHR; Eukaryota. DR GeneTree; ENSGT00940000163799; -. DR HOGENOM; CLU_070832_0_0_1; -. DR InParanoid; Q9UKJ0; -. DR OMA; GKWFWAT; -. DR OrthoDB; 5318725at2759; -. DR PhylomeDB; Q9UKJ0; -. DR TreeFam; TF338478; -. DR PathwayCommons; Q9UKJ0; -. DR Reactome; R-HSA-198933; Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell. DR SignaLink; Q9UKJ0; -. DR BioGRID-ORCS; 29990; 16 hits in 1148 CRISPR screens. DR GeneWiki; PILRB; -. DR GenomeRNAi; 29990; -. DR Pharos; Q9UKJ0; Tbio. DR PRO; PR:Q9UKJ0; -. DR Proteomes; UP000005640; Chromosome 7. DR RNAct; Q9UKJ0; Protein. DR Bgee; ENSG00000121716; Expressed in right testis and 93 other cell types or tissues. DR ExpressionAtlas; Q9UKJ0; baseline and differential. DR GO; GO:0005886; C:plasma membrane; TAS:Reactome. DR GO; GO:0042288; F:MHC class I protein binding; IBA:GO_Central. DR GO; GO:0007171; P:activation of transmembrane receptor protein tyrosine kinase activity; NAS:UniProtKB. DR GO; GO:0007169; P:transmembrane receptor protein tyrosine kinase signaling pathway; TAS:UniProtKB. DR Gene3D; 2.60.40.10; Immunoglobulins; 1. DR InterPro; IPR007110; Ig-like_dom. DR InterPro; IPR036179; Ig-like_dom_sf. DR InterPro; IPR013783; Ig-like_fold. DR InterPro; IPR003599; Ig_sub. DR PANTHER; PTHR15549; PAIRED IMMUNOGLOBULIN-LIKE TYPE 2 RECEPTOR; 1. DR PANTHER; PTHR15549:SF30; PAIRED IMMUNOGLOBULIN-LIKE TYPE 2 RECEPTOR ALPHA-RELATED; 1. DR SMART; SM00409; IG; 1. DR SUPFAM; SSF48726; Immunoglobulin; 1. DR PROSITE; PS50835; IG_LIKE; 1. DR Genevisible; Q9UKJ0; HS. PE 1: Evidence at protein level; KW 3D-structure; Alternative splicing; Glycoprotein; Immunoglobulin domain; KW Membrane; Receptor; Reference proteome; Signal; Transmembrane; KW Transmembrane helix. FT SIGNAL 1..19 FT /evidence="ECO:0000255" FT CHAIN 20..227 FT /note="Paired immunoglobulin-like type 2 receptor beta" FT /id="PRO_0000226822" FT TOPO_DOM 20..191 FT /note="Extracellular" FT /evidence="ECO:0000255" FT TRANSMEM 192..212 FT /note="Helical" FT /evidence="ECO:0000255" FT TOPO_DOM 213..227 FT /note="Cytoplasmic" FT /evidence="ECO:0000255" FT DOMAIN 21..143 FT /note="Ig-like V-type" FT CARBOHYD 100 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT VAR_SEQ 1 FT /note="M -> MGRASYGGSPVGHQSSSDHPRAKTCRSPVRDGPRTLCGVPTVALSLH FT FLREASSGSRTCGRRTSLCTSAKSSWTYRSGRLSWQSIKGTHLTITQALRQPLHRAPLL FT PGQLCWSPRPLEKNKAM (in isoform 3)" FT /evidence="ECO:0000303|PubMed:15498874" FT /id="VSP_017503" FT VAR_SEQ 23..227 FT /note="GSTGSGPSYLYGVTQPKHLSASMGGSVEIPFSFYYPWELAIVPNVRISWRRG FT HFHGQSFYSTRPPSIHKDYVNRLFLNWTEGQESGFLRISNLRKEDQSVYFCRVELDTRR FT SGRQQLQSIKGTKLTITQAVTTTTTWRPSSTTTIAGLRVTESKGHSESWHLSLDTAIRV FT ALAVAVLKTVILGLLCLLLLWWRRRKGSRAPSSDF -> LCEPALSELDRGSGERLPQD FT LKPAEGGPVCVFLPSRAGHPEIREAAVAVHQGDQTHHHPGCHNHHHLEAQQHNHHSRPQ FT GHRKQRALRIMAPKSGHCHQGCIGCRCAQNCHFGTAVPPPPVVEEKER (in FT isoform 2 and isoform 3)" FT /evidence="ECO:0000303|PubMed:15498874, FT ECO:0000303|PubMed:17974005" FT /id="VSP_017504" FT VARIANT 63 FT /note="I -> T (in dbSNP:rs11771799)" FT /id="VAR_059406" FT VARIANT 66 FT /note="N -> D (in dbSNP:rs11761306)" FT /id="VAR_059407" FT CONFLICT 63..66 FT /note="IVPN -> TAPD (in Ref. 2; CAC19193)" FT /evidence="ECO:0000305" FT CONFLICT 212 FT /note="Missing (in Ref. 2; CAC19193)" FT /evidence="ECO:0000305" FT STRAND 33..36 FT /evidence="ECO:0007829|PDB:4NFD" FT STRAND 39..43 FT /evidence="ECO:0007829|PDB:4NFD" FT STRAND 49..56 FT /evidence="ECO:0007829|PDB:4NFD" FT STRAND 68..75 FT /evidence="ECO:0007829|PDB:4NFD" FT STRAND 79..83 FT /evidence="ECO:0007829|PDB:4NFD" FT TURN 84..87 FT /evidence="ECO:0007829|PDB:4NFD" FT HELIX 91..93 FT /evidence="ECO:0007829|PDB:4NFD" FT STRAND 96..100 FT /evidence="ECO:0007829|PDB:4NFD" FT STRAND 106..112 FT /evidence="ECO:0007829|PDB:4NFD" FT HELIX 117..119 FT /evidence="ECO:0007829|PDB:4NFD" FT STRAND 121..134 FT /evidence="ECO:0007829|PDB:4NFD" FT STRAND 136..140 FT /evidence="ECO:0007829|PDB:4NFD" FT STRAND 145..149 FT /evidence="ECO:0007829|PDB:4NFD" SQ SEQUENCE 227 AA; 25542 MW; 7FF960C60AB7EF09 CRC64; MGRPLLLPLL LLLQPPAFLQ PGGSTGSGPS YLYGVTQPKH LSASMGGSVE IPFSFYYPWE LAIVPNVRIS WRRGHFHGQS FYSTRPPSIH KDYVNRLFLN WTEGQESGFL RISNLRKEDQ SVYFCRVELD TRRSGRQQLQ SIKGTKLTIT QAVTTTTTWR PSSTTTIAGL RVTESKGHSE SWHLSLDTAI RVALAVAVLK TVILGLLCLL LLWWRRRKGS RAPSSDF //